Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence | Zendy

Molly F. Franke | Zendy; Sasha C. Appleton | Zendy; Carole D. Mitnick | Zendy; Jennifer Furin | Zendy; J Bayona | Zendy; Katiuska Chalco | Zendy; S. S. Shin | Zendy; Megan Murray | Zendy; M. C. Becerra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence

Author(s) -

Molly F. Franke,

Sasha C. Appleton,

Carole D. Mitnick,

Jennifer Furin,

J Bayona,

Katiuska Chalco,

S. S. Shin,

Megan Murray,

M. C. Becerra

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis1008

Subject(s) - medicine , tuberculosis , regimen , interquartile range , hazard ratio , sputum , surgery , population , retrospective cohort study , confidence interval , pathology , environmental health

Recurrent tuberculosis disease occurs within 2 years in as few as 1% and as many as 29% of individuals successfully treated for multidrug-resistant (MDR) tuberculosis. A better understanding of treatment-related factors associated with an elevated risk of recurrent tuberculosis after cure is urgently needed to optimize MDR tuberculosis therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research